Literature DB >> 2418510

Cyclosporine.

S E Thomas, D S Gordon.   

Abstract

Cyclosporine is a fungal metabolite increasingly used as an immunosuppressive agent in organ transplantation. It provides immunosuppression primarily through reversible inhibition of T-lymphocytes, without myelotoxicity. Cyclosporine appears to inhibit primary activation of helper cells and to decrease the production of lymphokines by these cells. Cyclosporine becomes widely distributed into tissue compartments and is metabolized primarily by the liver. Serum trough levels, measured by radioimmunoassay or high pressure liquid chromatography, are commonly monitored and sometimes used for dose adjustments. Cyclosporine has been used in human renal, cardiac, liver, bone marrow, and pancreatic transplantation, as well as in other experimental animal models. It has a narrow therapeutic index, with major complications arising from nephrotoxicity, hypertension, and hepatotoxicity. Cyclosporine also has some antischistosomal and antimalarial activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418510     DOI: 10.1097/00007611-198602000-00017

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Effects of cyclosporin on C57BL/6 splenocytes before and after culture with high-dose recombinant interleukin-2: implications for immunosuppression with cyclosporin.

Authors:  F Sutherland; K Borkenhagen; L Temple; L D Bryant; R Lafreniere
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  Addition of cyclosporine to adalimumab improved psoriasis and adalimumab-induced injection site reaction.

Authors:  Satoshi Nakamizo; Yoshiki Miyachi; Kenji Kabashima
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.